Hope • June 9, 2026
Staggering Results Show HIV-Transmission Reduced 100% with Twice-Yearly Lenacapavir Injection
Originally published on Good News Network
A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants. Called PURPOSE 1, the aim of the first trial was testing a subcutaneous injection of the drug Lenacapavir given twice a year to people in a high-HIV-incidence country, which
A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants. Called PURPOSE 1, the aim of the first trial was testing a subcutaneous injection of the drug Lenacapavir given twice a year to people in a high-HIV-incidence country, which
Originally published on Good News Network.
More good news
- Amid Spokane fires, local bootmaker turns headquarters into refuge for firefighters, distributes new shoes for free
- Town’s Beloved Santa Claus Delivers a Very Special Present to Someone in Need–His Donated Kidney
- That time you learn you've been lying to yourself.
- Man recreates a 30 years photo of him and his dad, with his son